Evidence map›Paper›PMID 30619249›Full record

ArticleFrontiers in immunology2018

Butyrate Produced by Commensal Bacteria Down-Regulates

Camille Martin-Gallausiaux, Pierre Larraufie, Anne Jarry, Fabienne Béguet-Crespel, Ludovica Marinelli, Florence Ledue, Frank Reimann, Hervé M Blottière, Nicolas Lapaque

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Camille Martin-GallausiauxMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Pierre LarraufieMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Anne JarryCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
Fabienne Béguet-CrespelMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Ludovica MarinelliMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Florence LedueMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Frank ReimannMRC Metabolic Diseases Unit and Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
Hervé M BlottièreMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Nicolas LapaqueMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Université Paris-Saclay · FRAgroParisTech · FRInserm · FRMicrobiologie de l’alimentation au service de la santé · FRWellcome/MRC Institute of Metabolic Science · GBWellcome Trust · GB

Funding

Medical Research Council MC_UU_00014/3Medical Research Council MC_UU_12012/1Medical Research Council MC_UU_12012/3Wellcome Trust
6 · The paper itself

Abstract

Commensal bacteria are crucial for the development and maintenance of a healthy immune system therefore contributing to the global well-being of their host. A wide variety of metabolites produced by commensal bacteria are influencing host health but the characterization of the multiple molecular mechanisms involved in host-microbiota interactions is still only partially unraveled. The intestinal epithelial cells (IECs) take a central part in the host-microbiota dialogue by inducing the first microbial-derived immune signals. Amongst the numerous effector molecules modulating the immune responses produced by IECs, indoleamine 2,3-dioxygenase-1 (IDO-1) is essential for gut homeostasis.

Indexed as

BacteriaButyric AcidEpithelial CellsIndoleamine-Pyrrole 2,3,-DioxygenaseIntestinal MucosaCaco-2 CellsDown-RegulationFemaleGastrointestinal MicrobiomeGene Expression Regulation, DevelopmentalHumansInterferon-gammaMaleMiddle AgedReceptors, G-Protein-CoupledTranscription FactorsButyric AcidIDO1 protein, humanIFNG protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaReceptors, G-Protein-CoupledTranscription Factorsbutyrategut microbiotaIDO-1immune gene regulationintestinal epithelial cells

Identifiers

PMID30619249
PMCPMC6297836
OpenAlexW2902640082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.